Cargando…

Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat

Nicotine is acknowledged as the key addictive compound of tobacco. Varenicline (Champix(®) or Chantix(®)), mainly acting as a partial agonist at the α4β2 nicotinic receptor, is an approved smoking cessation pharmacotherapy, although with efficacy limited to a portion of smokers. Smokers differ in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Rivas, Vernon, Fiancette, Jean-François, Cannella, Nazzareno, Carbo-Gas, Maria, Renault, Prisca, Tostain, Jessica, Deroche-Gamonet, Véronique
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650579/ https://www.ncbi.nlm.nih.gov/pubmed/31379531 http://dx.doi.org/10.3389/fnbeh.2019.00159

Ejemplares similares

Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control
por: Wouda, Jelte A., et al.
Publicado: (2011)

Varenicline and Nicotine Replacement Use Associated With US Food and Drug Administration Drug Safety Communications
por: Desai, Ravi J., et al.
Publicado: (2019)

Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal
por: Perez, Xiomara A, et al.
Publicado: (2015)

Varenicline for Smoking Cessation: Nausea Severity and Variation in Nicotinic Receptor Genes
por: Swan, Gary E., et al.
Publicado: (2011)

Combination of varenicline and nicotine patch for smoking cessation: A case report
por: Young, Kelly M., et al.
Publicado: (2019)

Evaluation of the nicotine metabolite ratio in smoking patients treated with varenicline and bupropion
por: Tomaz, Paulo Roberto Xavier, et al.
Publicado: (2022)

Combination of behavioral therapy and varenicline for smoking cessation: Time to beat nicotine
por: Agarwal, Avnica, et al.
Publicado: (2022)

A Case Report on Varenicline Induced Delirium in an Alcohol and Nicotine Dependent Patient
por: Narayan, A. Lakshmi, et al.
Publicado: (2015)

2532: Predictive metabolism studies of varenicline and implications of its metabolites in nicotine addiction
por: Thompson, Keeshaloy, et al.
Publicado: (2018)

Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial
por: Tulloch, Heather E., et al.
Publicado: (2016)

Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α(4)β(2)-receptor partial agonist varenicline
por: Batsikadze, G., et al.
Publicado: (2017)

The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
por: Carlson, Eric C., et al.
Publicado: (2023)

Is a combination of varenicline and nicotine patch more effective in helping smokers quit than varenicline alone? A randomised controlled trial
por: Hajek, Peter, et al.
Publicado: (2013)

Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation
por: Ramon, Josep M, et al.
Publicado: (2014)

Integrating operant behavior and fiber photometry with the open-source python library Pyfiber
por: Conlisk, Dana, et al.
Publicado: (2023)

Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials
por: Chang, Ping-Hsun, et al.
Publicado: (2015)

Acute Effects of Nicotine Amplify Accumbal Neural Responses during Nicotine-Taking Behavior and Nicotine-Paired Environmental Cues
por: Guillem, Karine, et al.
Publicado: (2011)

The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats
por: Pentel, Paul R., et al.
Publicado: (2018)

Adaptive Smoking Cessation Using Precessation Varenicline or Nicotine Patch: A Randomized Clinical Trial
por: Davis, James M., et al.
Publicado: (2023)

Repeated administration of the GABA(B) receptor positive modulator BHF177 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine seeking in rats
por: Vlachou, Styliani, et al.
Publicado: (2010)

Prospective cohort study of the effectiveness of varenicline versus nicotine replacement therapy for smoking cessation in the “real world”
por: Kotz, Daniel, et al.
Publicado: (2014)

Profile of the Nicotinic Cholinergic Receptor Alpha 7 Subunit Gene Expression is Associated with Response to Varenicline Treatment
por: Santos, Juliana Rocha, et al.
Publicado: (2020)

Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol
por: Berlin, Ivan, et al.
Publicado: (2019)

377 Randomized Placebo-controlled Trial to Test the Efficacy of genetically informed biomarker Nicotine Metabolite Ratio (NMR), and transdermal nicotine replacement therapy (NRT) versus varenicline
por: Amadi-Onuoha, Obumneke
Publicado: (2023)

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
por: Aubin, H-J, et al.
Publicado: (2008)

Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens
por: Feduccia, A A, et al.
Publicado: (2014)

Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan
por: Madae’en, Saba, et al.
Publicado: (2020)

Varenicline Prevents LPS-Induced Inflammatory Response via Nicotinic Acetylcholine Receptors in RAW 264.7 Macrophages
por: Baris, Elif, et al.
Publicado: (2021)

A general theory of transition to addiction it was and a general theory of transition to addiction it is: Reply to the commentaries of Ahmed, Badiani, George & Koob, Kalivas & Gipson, and Tiffany
por: Piazza, Pier Vincenzo, et al.
Publicado: (2014)

A multistep general theory of transition to addiction
por: Piazza, Pier Vincenzo, et al.
Publicado: (2013)

Pharmacokinetic differences in nicotine and nicotine salts mediate reinforcement-related behavior: an animal model study
por: Han, Pengfei, et al.
Publicado: (2023)

Nicotine Self-Administration Induces Plastic Changes to Nicotinic Receptors in Medial Habenula
por: Jin, Xiao-Tao, et al.
Publicado: (2020)

Chronic nicotine pretreatment is sufficient to upregulate α4* nicotinic receptors and increase oral nicotine self-administration in mice
por: Renda, Anthony, et al.
Publicado: (2014)

Cue restricted smoking increases quit rates with varenicline
por: Scholz, Jaqueline R., et al.
Publicado: (2021)

Comparative Effectiveness of Varenicline and Nicotine Replacement Therapy for Smoking Cessation in Older and Younger Smokers: A Prospective Cohort in Taiwan
por: Chang, Po-Yin, et al.
Publicado: (2019)

Long-term effectiveness and safety of varenicline and nicotine replacement therapy in people with neurodevelopmental disorders: A prospective cohort study
por: Itani, Taha, et al.
Publicado: (2019)

β2* nicotinic acetylcholine receptor subtypes mediate nicotine-induced enhancement of Pavlovian conditioned responding to an alcohol cue
por: Maddux, Jean-Marie, et al.
Publicado: (2022)

High Reinforcing Efficacy of Nicotine in Non-Human Primates
por: Le Foll, Bernard, et al.
Publicado: (2007)

Varenicline Combined With Oral Nicotine Replacement Therapy and Smartphone-Based Medication Reminders for Smoking Cessation: Feasibility Randomized Controlled Trial
por: Sifat, Munjireen, et al.
Publicado: (2023)

Cue Reactivity in Nicotine and Alcohol Addiction: A Cross-Cultural View
por: Lv, Wanwan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jpbptjfq2bv2jlof48bpih1jsh